LEBWOHL, M.; STROBER, B.; SCHRADER, A.; LI, A.; ECKMANN, T.; ZHU, B.; MALATESTINIC, W.; BIRT, J.; FEELY, M.; BLAUVELT, A. 6-Month Real World Study to Assess the Effectiveness of Ixekizumab After Switching from IL-23 Inhibitors and Other Biologic Therapies: The CorEvitas Psoriasis Registry. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 7, n. 6, p. s232, 2023. DOI: 10.25251/skin.7.supp.232. Disponível em: https://jofskin.org/33014/index.php/skin/article/view/2337. Acesso em: 3 jul. 2024.